FGF1(成纤维细胞生长因子1)是一种重要的生长因子,属于FGF基因家族,该家族包含22个成员,主要参与细胞增殖、分化、迁移和存活等生物学过程。FGF家族成员的共性是它们通过结合FGF受体(FGFR)并激活下游信号通路(如MAPK、PI3K-AKT等)来调控多种生理功能。FGF1是一种非糖基化蛋白,具有广泛的生物学活性,尤其在组织修复、血管生成和伤口愈合中发挥关键作用。它的主要作用位点包括内皮细胞、成纤维细胞和神经元等,通过促进这些细胞的增殖和迁移来参与组织再生。FGF1的突变可能导致其功能异常,例如失去与受体的结合能力或信号传导障碍,进而影响组织修复和血管形成,甚至与某些疾病如癌症、糖尿病和心血管疾病相关。研究表明,FGF1的过表达可能促进肿瘤血管生成和癌细胞生长,而降低表达则可能延缓伤口愈合或导致组织再生能力下降。此外,FGF1在代谢调控中也具有重要作用,例如它能够改善胰岛素敏感性,因此在糖尿病治疗中具有潜在应用价值。FGF1还与其他基因如VEGF(血管内皮生长因子)和PDGF(血小板衍生生长因子)协同作用,共同调节血管生成和组织修复。由于FGF1的多功能性,它在再生医学和疾病治疗领域备受关注,但过度激活也可能带来副作用,如促进肿瘤进展,因此其应用需谨慎调控。
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth and invasion. This protein functions as a modifier of endothelial cell migration and proliferation, as well as an angiogenic factor. It acts as a mitogen for a variety of mesoderm- and neuroectoderm-derived cells in vitro, thus is thought to be involved in organogenesis. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Jan 2009]
由该基因编码的蛋白质是成纤维细胞生长因子(FGF)家族的一个成员。 FGF家族成员具有广泛的促有丝分裂和细胞存活的活动,并参与各种生物学过程,包括胚胎发育,细胞生长,形态发生,组织修复,肿瘤生长和侵袭。该蛋白质作为内皮细胞迁移和增殖的改性剂,以及血管生成因子。它作为用于各种体外mesoderm-和神经外胚层来源的细胞的有丝分裂原,从而被认为是参与器官发生。编码不同同种型的多个可变剪接变体已有描述。 [由RefSeq的,2009年1月提供]
FGF1基因(以及对应的蛋白质)的细胞分布位置:
FGF1基因的本体(GO)信息:
名称 |
---|
4014 Ras signaling pathway [PATH:hsa04014] |
4015 Rap1 signaling pathway [PATH:hsa04015] |
4010 MAPK signaling pathway [PATH:hsa04010] |
4390 Hippo signaling pathway [PATH:hsa04390] |
4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
4810 Regulation of actin cytoskeleton [PATH:hsa04810] |
5200 Pathways in cancer [PATH:hsa05200] |
5218 Melanoma [PATH:hsa05218] |
名称 |
---|
Activated point mutants of FGFR2 |
Adaptive Immune System |
Constitutive Signaling by Aberrant PI3K in Cancer |
DAP12 interactions |
DAP12 signaling |
Disease |
Diseases of signal transduction |
Downstream signal transduction |
Downstream signaling events of B Cell Receptor (BCR) |
Downstream signaling of activated FGFR1 |
Downstream signaling of activated FGFR2 |
Downstream signaling of activated FGFR3 |
Downstream signaling of activated FGFR4 |
Fc epsilon receptor (FCERI) signaling |
FGFR1 ligand binding and activation |
FGFR1 mutant receptor activation |
FGFR1b ligand binding and activation |
FGFR1c ligand binding and activation |
FGFR2 ligand binding and activation |
FGFR2 mutant receptor activation |
FGFR2b ligand binding and activation |
FGFR2c ligand binding and activation |
FGFR3 ligand binding and activation |
FGFR3 mutant receptor activation |
FGFR3b ligand binding and activation |
FGFR3c ligand binding and activation |
FGFR4 ligand binding and activation |
FRS-mediated FGFR1 signaling |
FRS-mediated FGFR2 signaling |
FRS-mediated FGFR3 signaling |
FRS2-mediated FGFR4 signaling |
GAB1 signalosome |
IGF1R signaling cascade |
Immune System |
Innate Immune System |
Insulin receptor signalling cascade |
IRS-mediated signalling |
IRS-related events |
IRS-related events triggered by IGF1R |
Negative regulation of FGFR1 signaling |
Negative regulation of FGFR2 signaling |
Negative regulation of FGFR3 signaling |
Negative regulation of FGFR4 signaling |
NGF signalling via TRKA from the plasma membrane |
Phospholipase C-mediated cascade; FGFR2 |
Phospholipase C-mediated cascade; FGFR3 |
Phospholipase C-mediated cascade; FGFR4 |
Phospholipase C-mediated cascade: FGFR1 |
PI-3K cascade:FGFR1 |
PI-3K cascade:FGFR2 |
PI-3K cascade:FGFR3 |
PI-3K cascade:FGFR4 |
PI3K Cascade |
PI3K events in ERBB2 signaling |
PI3K events in ERBB4 signaling |
PI3K/AKT activation |
PI3K/AKT Signaling in Cancer |
PIP3 activates AKT signaling |
Role of LAT2/NTAL/LAB on calcium mobilization |
SHC-mediated cascade:FGFR1 |
SHC-mediated cascade:FGFR2 |
SHC-mediated cascade:FGFR3 |
SHC-mediated cascade:FGFR4 |
Signal Transduction |
Signaling by activated point mutants of FGFR1 |
Signaling by activated point mutants of FGFR3 |
Signaling by EGFR |
Signaling by ERBB2 |
Signaling by ERBB4 |
Signaling by FGFR |
Signaling by FGFR in disease |
Signaling by FGFR1 |
Signaling by FGFR1 in disease |
Signaling by FGFR1 mutants |
Signaling by FGFR2 |
Signaling by FGFR2 in disease |
Signaling by FGFR2 mutants |
Signaling by FGFR3 |
Signaling by FGFR3 in disease |
Signaling by FGFR3 mutants |
Signaling by FGFR4 |
Signaling by FGFR4 in disease |
Signaling by FGFR4 mutants |
Signaling by Insulin receptor |
Signaling by PDGF |
Signaling by SCF-KIT |
Signaling by the B Cell Receptor (BCR) |
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) |
Signalling by NGF |
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Mesothelioma | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Myocardial Ischemia | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Pulmonary Fibrosis | 0.120271442 | 2 | 0 | BeFree_CTD_human |
leukemia | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Hypotension | 0.12 | 1 | 0 | CTD_human |
Weight Gain | 0.12 | 1 | 0 | CTD_human |
Cardiac Hypertrophy | 0.12 | 1 | 1 | GWASCAT |
Reperfusion Injury | 0.08 | 1 | 0 | RGD |
Brain Ischemia | 0.08 | 1 | 0 | RGD |
Alzheimer's Disease | 0.010096888 | 4 | 0 | BeFree_GAD_LHGDN |
山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼
电话: 0531-88819269
E-mail: product@genelibs.com
关注微信订阅号,实时查看信息,关注医学生物学动态。